A generic version of Risdiplam, a medicine used to treat spinal muscular atrophy (SMA), could soon be available in India at $183.47 dollars per bottle, a sharp 97% drop from the current rate of $7,150 dollars. The news has been…

A generic version of Risdiplam, a medicine used to treat spinal muscular atrophy (SMA), could soon be available in India at $183.47 dollars per bottle, a sharp 97% drop from the current rate of $7,150 dollars. The news has been…